IKONICS Corporation Annual Report 2012

← All annual reports

FY2012 Annual Report · IKONICS Corporation

Loading PDF…

2
1
0
2

ANNUAL
REPORT

Corporation

NASDAQ lISTED: IKNX

CONTENTS

COmPanY OVERViEW

IKONICS is a corporation with four important technology platforms: ultraviolet (uV)
reactive chemistry, film coating and construction, industrial inkjet printing and
technical powder blasting. IKONICS combines these technologies in various ways
to create products and services for screen printers, manufacturers of awards and
trophies, manufacturers of textured molds for plastic injection, and the custom
machining of advanced composite materials and electronic wafers.

IKONICS customer base includes over 25,000 end-users of its screen printing and
awards and trophy products, suppliers to the worldwide automotive industry, and
major civilian and military electronics and aerospace companies. IKONICS products
and services are used to manufacture products that range from T-shirts to the lat-
est automobiles to the most advanced commercial and military aircraft.

IKONICS key technologies are developed internally, and the Company has a strong
patent and trade secret position. All manufacturing is done in Duluth.

This range of technologies, markets, and the Company’s strong financial condition
makes IKONICS a very robust company, and the Company believes it is buffered
against many of the vagaries of the market and the economy. IKONICS’ com-
mitment to a range of new technologies gives the Company substantial growth
potential.

Letter to Shareholders ............................................................................1

Management’s Discussion and Analysis of
Financial Condition and Results of Operations ..........................................2

Critical Accounting Policies and Estimates ...............................................2

Results of Operations .............................................................................3

Market for Common Equity and
Related Stockholder Matters ...................................................................5

Management’s Report ............................................................................5

Management’s Annual Report on
Internal Control Over Financial Reporting .................................................6

Report of Independent
Registered Public Accounting Firm ..........................................................6

Balance Sheets ......................................................................................7

Statements of Income ............................................................................8

Statements of Stockholders’ Equity.......................................... ................8

Statements of Cash Flows.......................................................................9

Notes to Financial Statements .................................................................10

IKONICS Five-Year History .......................................................................Back Cover

CORPORATE PROFILE

2012 Net Sales ................................................................................$17,312,407

Earnings per common share (diluted) ............................................................ $0.35

Company founded ....................................................................................... 1952

Employees ...................................................................................................... 73

NASDAQ Symbol .......................................................................................... IKNX

Letter to SharehoLderS

The year ended on a strong note with 2012 fourth quarter sales up 8% compared to the fourth quarter of 2011, and earnings at $0.14 per share, representing a 109%
increase compared to the fourth quarter of 2011. The Company ended 2012 with record sales of $17,312,000 – a 3% increase over 2011. Earnings for the year ended up
at $0.35 per share – essentially the same as 2011.

While our patient investment in DTX and Micro-Machining technologies continues to depress earnings, significant progress was made, particularly with our Micro-Machining
customers in the aerospace industry. In addition to ongoing business related to the Boeing 747-8, we have received a blanket order for product for the Airbus A350, which
we expect to grow as the A350 is placed into production. We also have orders, beginning in 2013, for acoustic liners from a major jet engine manufacturer, and I anticipate
that this product line will grow during the year. Consequently, we are expanding our manufacturing capability, adding both equipment and people. I believe that these excit-
ing developments not only portend a profitable business for IKONICS, but are a validation of our unique technology by a very sophisticated industry.

During the year, we also invested significantly in strengthening our patent position for both Micro-Machining and DTX. Our domestic screen print market was also a star
performer in 2012, with sales up 7% over last year while competing in a difficult market.

During the fourth quarter of 2012, we paid a $1.00 per share, one-time special cash dividend, amounting to approximately $2,000,000. As of December 31, 2012, we had
$2.4 million of cash and short-term investments compared to $3.9 million at the end of the third quarter of 2012, and we continue to generate a strong cash flow. I believe
our current cash and investments and their projected growth is more than sufficient to meet our growth plans. We have no long term debt.

William C. Ulland

Chairman, President & CEO

March 19, 2013

ManageMent’S diScuSSion and anaLySiS of
financiaL condition and reSuLtS of operationS

The following management discussion and analysis focuses on those factors that
had a material effect on the Company’s financial results of operations and financial
condition during 2012 and 2011 and should be read in connection with the Com-
pany’s audited financial statements and notes thereto for the years ended December
31, 2012 and 2011, included herein.

FACTOrS ThAT MA y AFFECT FuTurE rESul TS

Certain statements made in this Annual report, including those summarized below,
are forward-looking statements within the meaning of the safe harbor provisions of
Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks
and uncertainties, and actual results may differ. Factors that could cause actual
results to differ include those identified below.

The expectation that the Company will obtain a similar line of credit when its cur-
rent line of credit expires in October 2013. The belief that the Company’s current
financial resources, cash generated from operations and the Company’s capacity
for debt and/or equity financing will be sufficient to fund current and anticipated
business operations and capital expenditures. The belief that the Company’s low
debt levels and available line of credit make it unlikely that a decrease in product
demand would impair the Company’s ability to fund operations – Changes in
anticipated operating results, credit availability, equity or debt market conditions,
macroeconomic conditions or the Company’s debt levels may further enhance or
inhibit the Company’s ability to maintain or raise appropriate levels of cash or to
renew its line of credit.

The Company’s expectations as to the level and use of planned capital expendi-
tures and that capital expenditures will be funded with cash generated from op-
erating activities – This expectation may be affected by changes in the Company’s
anticipated capital expenditure requirements resulting from unforeseen required
maintenance, repairs or capital asset additions. The funding of planned or unfore-
seen expenditures may also be affected by changes in anticipated operating results
resulting from decreased sales, lack of acceptance of new products, increased
operating expenses, changes to the aerospace industry or the production timelines
of the Company’s customers in that industry or by other unexpected events affecting
the Company’s financial position.

The Company’s belief that its vulnerability to foreign currency fluctuations and
general economic conditions in foreign countries is not significant – This belief
may be impacted by economic, political and social conditions in foreign markets,
changes in regulatory and competitive conditions, a change in the amount or
geographic focus of the Company’s international sales, or changes in purchase or
sales terms.

The Company’s plans to continue to invest in research and development efforts,
expedite internal product development and form technological alliances, as
well as the expected focus and results of such investments – These plans and
expectations may be impacted by general market conditions, unanticipated changes
in expenses or sales, delays in the development of new products, technological ad-
vances, the ability to find suitable and willing technology partners or other changes
in competitive or market conditions.

The Company’s belief that its Chromaline Screen Print Product and IKONICS
Imaging units will continue to grow and prosper – The growth and results from
these units will depend on the strength of the u.S. economy overall, the cost of raw
materials, new product introductions by the Company’s current competitors or new
competitors and maintenance of the Company’s reputation for high-quality products.

The Company’s expectation that it will continue efforts to grow its business
internationally – The time management has to focus on international expansion,
the sufficiency of the Company’s financial resources and results of operation to
support international expansion, the success of the Company’s existing international
operations, changes in foreign laws, and global political, social or economic events
(including terrorist attacks and security concerns in general) could influence the
level of the Company’s efforts to grow its business internationally.

criticaL accounting poLicieS and eStiMateS

The Company prepares its financial statements in conformity with accounting prin-
ciples generally accepted in the united States of America. Therefore, the Company is
required to make certain estimates, judgments and assumptions that the Company
believes are reasonable based upon the information available. These estimates and
assumptions affect the reported amounts of assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses during the
periods presented. The accounting policies and estimates which IKONICS believes
are the most critical to aid in fully understanding and evaluating its reported finan-
cial results include the following:

Trade Receivables – The Company performs ongoing credit evaluations of its
customers and adjusts credit limits based upon payment history and the customer’s
current credit worthiness, as determined by review of the current credit information.
The Company continuously monitors collections and payments from its custom-
ers and maintains a provision for estimated credit losses based upon historical
experience and any specific customer collection issues that have been identified.
While such credit losses have historically been within expectations and the provi-
sions established, the Company cannot guarantee that it will continue to experience
the same collection history that has occurred in the past. The general payment
terms are net 30-45 days for domestic customers and net 30-90 days for foreign
customers. A small percentage of the trade receivables balance are denominated
in a foreign currency with no concentration in any given country. At the end of each
reporting period, the Company analyzes the receivable balance for customers paying
in a foreign currency. These balances are adjusted to each quarter or year end spot
rate in accordance with FASB ASC 830, Foreign Currency Matters.

inventories – Inventories are valued at the lower of cost or market value using the
last in, first out (lIFO) method. The Company monitors its inventory for obsolescence
and records reductions from cost when required.

Self-Funded medical insurance – Beginning in January 2012, the Company
moved from a fully insured to a self-funded medical insurance plan. The Company
contracted with an administrative service company or a “third party administrator”
to supervise and administer the program and act as the Company’s fiduciary and
representative. The Company has reduced its risk under this self-funded plan by
purchasing both specific and aggregate stop-loss insurance coverage for individual
claims and total annual claims in excess of prescribed limits. The Company records
estimates for claim liabilities based on information provided by the third-party
administrators, historical claims experience, the life cycle of claims, expected costs
of claims incurred but not paid, and expected costs to settle unpaid claims. The
Company regularly monitors its estimated insurance-related liabilities. Actual claims
experience may differ from the Company’s estimates. Costs related to the admin-
istration of the plan and related claims are expensed as incurred. The total liability
for self-funded medical insurance was $54,000 as of December 31, 2012 and is
included within other accrued expenses in the consolidated balance sheet.

income Taxes – At December 31, 2012, the Company had net current deferred
tax assets of $142,000 and net noncurrent deferred tax liabilities of $366,000.
The deferred tax assets and liabilities result primarily from temporary differences
in property and equipment, accrued expenses, and inventory reserves. In connec-

IKONICS COrpOratION | 2012 AnnuAl RepoRttion with the recording of an impairment charge that occurred prior to 2011 as
described below, the Company has recorded a deferred tax asset and correspond-
ing full valuation allowance in the amount of $323,000 as it is more likely than
not that this asset will not be realized. As of December 31, 2012 the fully reserved
$323,000 deferred tax asset related to the capital loss can be carried forward two
years and must be offset by a capital gain. The Company has determined that is
more likely than not that the remaining deferred tax assets will be realized and that
an additional valuation allowance for such assets in not currently required. The
Company accounts for its uncertain tax positions under the provision of FASB ASC
740, Income Taxes. At December 31, 2012 and 2011, the Company had no reserves
for uncertain tax positions.

Revenue Recognition – The Company recognizes revenue on sales of products
when title passes which can occur at the time of shipment or when the goods ar-
rive at the customer location depending on the agreement with the customer. The
Company sells its products to both distributors and end-users. Sales to distributors
and end-users are recorded based upon the criteria governed by the sales, delivery,
and payment terms stated on the invoices from the Company to the purchaser. In
addition to transfer of title / risk of loss, all revenue is recorded in accordance with
the criteria outlined within SAB 104 and FASB ASC 605 revenue recognition:

a.) persuasive evidence of an arrangement (principally in the form of customer

sales orders and the Company’s sales invoices)

b.) delivery and performance (evidenced by proof of delivery, e.g. the shipment
of film and substrates with bill of lading used for proof of delivery for FOB
shipping point terms, and the carrier booking confirmation report used for
FOB destination terms). Once the finished product is shipped and physically
delivered under the terms of the invoice and sales order, the Company has
no additional performance or service obligations to complete

c.) a fixed and determinable sales price (the Company’s pricing is established

and is not based on variable terms, as evidenced in either the Company’s in-
voices or the limited number of distribution agreements; the Company rarely
grants extended payment terms and has no history of concessions)

d.) a reasonable likelihood of payment (the Company’s terms are standard, and
the Company does not have a substantial history of customer defaults or
non-payment)

Sales are reported on a net basis by deducting credits, estimated normal returns
and discounts. The Company’s return policy does not vary by geography. The
customer has no rotation or price protection rights and the Company is not under a
warranty obligation. Freight billed to customers is included in sales. Shipping costs
are included in cost of goods sold.

reSuLtS of operationS
yEAr ENDED DECEMBEr 31, 2012 COMPArED TO yEAr ENDED DECEMBEr 31, 2011

Machining due to a temporary purchasing delay at a large aerospace customer
and a non-repeating contract the Company fulfilled in 2011 in addition to the
Company deemphasizing the machining of marginally profitable electronic wafers
and shifting its emphasis to the machining of composites for the aerospace indus-
try. Weaker sales to the Middle East resulted in a 0.5% decrease in Export sales
as sales dropped from $5.6 million in 2011 to $5.5 million in 2012.

Gross Profit – Gross profit in 2012 was $6.9 million, or 40.1% of sales, compared
to $6.7 million, or 40.0% of sales in 2011. Domestic, Export and IKONICS Imaging
all realized small gross profit percentage improvement. The gross margin percent-
age increases were mainly due to a combination of higher sales volumes and price
increases. The Other gross margin decreased from 58.0% in 2011 to 39.3% in the
2012 period due to a decrease in the higher margin Micro-Machining sales and the
sale of a lower margin DTX printer which did not occur in 2011.

Selling, General and administrative Expenses – Selling, general and administra-
tive expenses were $5.3 million, or 30.5% of sales, in 2012 compared to $5.2 mil-
lion, or 30.8% of sales in 2011. The increase in selling, general and administrative
expenses reflects higher expenses to support the Company’s DTX initiative along
with increased Export sales expenses related to the Company’s efforts to expand
its presence in both Europe and Asia. lower Domestic and IKONICS Imaging sales
expenses along with a decrease in Micro-Machining consulting expenses partially
offset these increases.

Research and development Expenses – research and development expenses
in 2012 were $630,000, or 3.6% of sales, versus $512,000, or 3.1% of sales, in
2011. The 2012 increase is partially related to a $23,000 abandonment of patent
applications. The Company records patent application costs as an asset and amor-
tizes those costs upon successful completion of the application process or expenses
those costs when an application is abandoned. Additional costs were also incurred
for increased staffing and production trials along with higher lab supply expenses.

interest income – The Company earned $12,000 of interest income in 2012
compared to $17,000 in 2011. The interest earned in 2012 and 2011 is related to
interest received from the Company’s short-term investments, which consist of fully
insured certificates of deposit with remaining maturities ranging from 3 to 8 months.

income Taxes – During 2012, the Company realized income tax expense of
$351,000, or an effective rate of 33.6%, compared to income tax expense of
$345,000, or an effective rate of 33.1%, for the same period in 2011. The income
tax provision for the 2012 and 2011 periods differs from the expected tax expense
due to the benefits of the domestic manufacturing deduction and state credits for
research and development. The 2011 income tax provision also benefitted from
federal credits for research and development. The 2012 income provision did not
benefit from federal credits for research and development as these credits were not
approved until after December 31, 2012.

Liquidity and capitaL reSourceS

Sales – The Company’s net sales increased 3.2% in 2012 to a record $17.3
million compared to net sales of $16.8 million in 2011. Domestic realized a 6.6%
sales increase as sales grew from $6.7 million in 2011 to $7.1 million in 2012,
as both film and emulsion sales were stronger in 2012 due to improved distribu-
tion in the central region of the united States. IKONICS Imaging also realized
a 3.5% sales increase in 2012. IKONICS Imaging’s growth was mainly due to
improved equipment sales volumes. Other sales in 2012 of $1.0 million were flat
with 2011 sales. Other sales in 2012 benefitted from improved DTX film sales and
the sale of a DTX printer. The Company anticipates that in the future, DTX printer
sales will be made directly by its strategic printer manufacturing partners and not
the Company. Offsetting these increases in Other sales were decreases in Micro-

The Company has financed its operations principally with funds generated from op-
erations. These funds have been sufficient to cover the Company’s normal operating
expenditures, annual capital requirements, research and development expenditures,
and a one-time dividend distribution.

Cash and cash equivalents were $968,000 and $1,867,000 at December 31, 2012
and 2011, respectively. In addition to its cash, the Company also held $1,442,000
of short-term investments as of December 31, 2012 and $1,835,000 of short-
term investments as of December 31, 2011. The Company generated $1,182,000
in cash from operating activities during 2012, compared to generating $794,000
of cash from operating activities in 2011. Cash provided by operating activities

is primarily the result of the net income adjusted for non cash depreciation and
amortization, deferred taxes, and certain changes in working capital components
discussed in the following paragraph.

During 2012, inventories increased by $444,000. In addition to increased finished
goods levels, part of the inventory increase is related to increased raw material
purchases to take advantage of volume discounts and to protect against future
price increases. The trade receivables decrease of $121,000 is related to improved
collections. The $42,000 increase in prepaid expenses and other assets is related
to the purchases of equipment utilized for sales promotion. Accounts payable
increased $44,000 due to the timing of payments to and purchases from vendors
while accrued liabilities increased $58,000 due to the timing of the Company’s
payroll and customer prepayments. Income taxes payable increased $84,000 and
the Company’s income tax receivable decreased $59,000 due to timing of estimated
2012 tax payments compared to the calculated 2012 tax liability.

During 2012, investing activities used $172,000. Purchases of property and equip-
ment were $567,000, mainly for manufacturing equipment, mandatory elevator
upgrades and three vehicles. The Company realized $59,000 in proceeds from the
sale of three vehicles and on a like-kind equipment exchange. Also in 2012, the
Company incurred $57,000 in patent application costs that the Company records as
an asset and amortizes upon successful completion of the application process. The
Company also invested $1,858,000 in nine fully insured certificates of deposit dur-
ing 2012. Eleven certificates of deposit totaling $2,250,000 matured during 2012.

During 2011, investing activities used $289,000. The Company’s purchases of
property and equipment for the year were $622,000. These purchases were mainly
for equipment to upgrade the capabilities of the Company’s DTX and Micro-Machin-
ing operations, equipment to improve product quality and capacity, mandatory eleva-
tor improvements, one vehicle and hardware to upgrade the Company’s computer
network. Also during 2011, the Company incurred $60,000 in patent application
costs that the Company records as an asset and amortizes upon successful comple-
tion of the application process. The Company also invested $2,446,000 in twelve
fully insured certificates of deposits during 2011. Fourteen certificates of deposit
totaling $2,829,000 matured during 2011.

In 2012, financing activities used $1,909,000 as the Company declared and paid
a one-time special cash dividend of $1.00 per share. The total dividend paid was
$1,998,000. The Company also received $89,000 from the issuance of 13,888
shares of common stock from the exercise of stock options. During 2011, the Com-
pany received $71,000 from financing activities as the Company received $73,000
from the issuance of 11,500 shares of common stock from the exercise of stock op-
tions. The Company used $2,100 in financing activities during 2011 to repurchase
270 shares of its own stock.

A bank line of credit exists providing for borrowings of up to $1,250,000 through
October 30, 2013. The Company expects to obtain a similar line of credit when the
current line of credit expires. The line of credit is collateralized by trade receivables
and inventories and bears interest at 2.5 percentage points over the 30-day lIBOr
rate. The Company did not utilize this line of credit during 2012 and 2011 and there
were no borrowings outstanding as of December 31, 2012 and 2011. There are no
financial covenants related to the line of credit.

The Company believes that current financial resources, its line of credit, cash gener-
ated from operations and the Company’s capacity for debt and/or equity financing
will be sufficient to fund current and anticipated business operations. The Company
also believes that its low debt levels and available line of credit make it unlikely that
a decrease in demand for the Company’s products would impair the Company’s abil-
ity to fund operations.

capitaL expenditureS

During 2012, the Company had $567,000 of capital expenditures. Capital expen-
ditures in 2012 were mainly for manufacturing equipment upgrades to increase
capacity and improve product quality. The Company also incurred expenditures
related to mandatory elevator upgrades and the purchase of three vehicles.

In 2011, the Company had $622,000 in capital expenditures. Capital expenditures
in 2011 were for equipment to upgrade the capabilities of the Company’s DTX and
Micro-Machining operations, equipment to improve product quality and capacity,
mandatory elevator improvements, one vehicle and hardware to upgrade the Com-
pany’s computer network. In addition, the Company transferred $227,000 of DTX
equipment from inventory to equipment during the year. The DTX equipment was
purchased for inventory in 2010. Instead of offering the DTX equipment for sale, the
Company decided it would be necessary to keep the equipment for product testing
and customer demonstrations.

The Company expects capital expenditures in 2013 of approximately $725,000.
The planned expenditures primarily will be for manufacturing equipment necessary
for anticipated Micro-Machining aerospace business. The Company will also incur
expenditures to improve its ability to test and demonstrate products. These commit-
ments are expected to be funded with cash generated from operating activities.

internationaL activity

The Company markets its products in numerous countries in all regions of the world,
including North America, Europe, latin America, and Asia. The Company’s 2012
foreign sales of $5,523,000 were approximately 31.9% of total sales, compared
to the 2011 foreign sales of $5,556,000, which were 33.1% of total sales. The
small decrease in foreign sales in 2012 was primarily due to a 20.0% decrease in
sales to the Middle East. The Company is exposed to the risk of changes in social,
political, and economic conditions inherent in foreign operations, and the Company’s
results of operations are affected by fluctuations in foreign currency exchange rates.
Fluctuations in foreign currencies have not significantly impacted the Company’s
operations because the Company’s foreign sales are not concentrated in any one
region of the world. The Company believes its vulnerability to uncertainties due to
foreign currency fluctuations and general economic conditions in foreign countries is
not significant.

The Company’s foreign transactions are primarily negotiated, invoiced and paid in
u.S. dollars, while a portion is transacted in Euros. IKONICS has not implemented an
economic hedging strategy to reduce the risk of foreign currency translation expo-
sures, which management does not believe to be significant based on the scope and
geographic diversity of the Company’s foreign operations as of December 31, 2012.
Furthermore, the impact of foreign exchange on the Company’s balance sheet and
operating results was not material in either 2012 or 2011.

future outLook

IKONICS has spent on average approximately 3%- 4% of its sales dollars for the
past few years in research and development and has made capital expenditures re-
lated to its DTX and Micro-Machining programs. The Company plans to maintain its
efforts in this area and expedite internal product development as well as form tech-
nological alliances with outside experts to commercialize new product opportunities.

The Company continues to make progress on its new Micro-Machining business
initiative. The Company has entered into agreements with several major aerospace
companies to determine the feasibility of using its unique technologies in the
production of military and commercial aircraft. The Company is currently supplying
products to two aerospace companies for use in the construction of new generation

IKONICS COrpOratION | 2012 AnnuAl RepoRtcommercial aircraft. Although sequestration of the Department of Defense budget
and delays in the launching of new commercial aircraft fleets could adversely affect
some of these sales, progress is being made on a number of its in-house feasibility
projects, and the Company believes that several of these could lead to ongoing busi-
ness. In anticipation of this business, the Company is expanding its Micro-Machining
manufacturing capacity.

As of February 23, 2013, the Company had approximately 633 shareholders. Decla-
ration and payment of dividends is within the sole discretion of the Company’s board
of directors. During the fourth quarter of 2012, the Company declared a one-time
special cash dividend of $1.00 per share, paid on December 31, 2012, amounting
to $1,998,475. This was the first and only cash dividend paid in the Company’s
history.

ManageMent’S report

The financial statements of IKONICS Corporation have been prepared by Company
management who are responsible for their content. These statements have been
prepared in accordance with accounting principles generally accepted in the united
States of America and, where appropriate, reflect estimates based on judgements of
management.

The financial statements have been audited by McGladrey llP, an indepen dent
registered public accounting firm.

The Audit Committee of the Board of Directors, comprised of outside directors,
meets periodically with the independent auditors and management to discuss
the company’s internal accounting controls and financial reporting matters. Our
independent regis tered public accounting firm has unrestricted access to the Audit
Committee, without management present, to discuss the results of their audit, the
adequacy of internal accounting controls, and the quality of financial reports.

William C. Ulland

jOn GERlaCH

Chairman, President & CEO

Chief Financial Officer & V.P. Finance

The Company is also continuing to make progress on its DTX business initiatives.
In addition to its growing inkjet technology business, the Company is having a good
market reception to its complementary photographic technology film aimed at small-
er users and has introduced a fluid for use in protoyping. The Company is currently
working with its DTX customers on training, production optimization, and product
improvements. The Company has been awarded European and united States patents
on its DTX technologies.

Domestically, both the Chromaline Screen Print Product and its IKONICS Imaging
units remain profitable mature markets and require aggressive strategies to grow
market share. Although there will be challenges, the Company believes these busi-
nesses will continue to grow and prosper. In addition to its traditional emphasis on
domestic markets, the Company will continue efforts to grow its business interna-
tionally by attempting to develop new markets and expanding market share where it
has already established a presence.

Other future activities undertaken to expand the Company’s business may include
acquisitions, building improvements, equipment additions, new product development
and marketing opportunities.

off-baLance Sheet arrangeMentS

The Company has no off-balance sheet arrangements.

recent accounting pronounceMentS

None

Market for coMMon equity and reLated
StockhoLder MatterS

The Company’s Common Stock is traded on the Nasdaq Capital Market under the
symbol IKNX. The following table sets forth, for the fiscal quarters indicated, the high
and low sales prices for the Company’s Common Stock as reported on the Nasdaq
Capital Market for the periods indicated.

Fiscal Year Ended december 31, 2012:

First Quarter

Second Quarter

Third Quarter

Fourth Quarter

Fiscal Year Ended december 31, 2011:

First Quarter

Second Quarter

Third Quarter

Fourth Quarter

High

low

$ 9.10

$ 7.03

9.35

9.45

9.39

7.54

7.70

7.75

$ 8.94

$ 6.90

8.75

8.50

8.77

7.46

7.25

7.30

ManageMent’S annuaL report on internaL controL over financiaL reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in rules 13a-15(f) and 15d-15(f ) under
the Exchange Act. Our internal control system is designed to provide reasonable assurance to our management and board of directors regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Our internal control over financial
reporting includes those policies and procedures that:

• Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;

• Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

• Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material

effect on the financial statements.

Management assessed the effectiveness of our internal control over financial reporting as of December 31, 2012. In making this assessment, management used the criteria
set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control – Integrated Framework. Based on management’s assess-
ment and those criteria, management believes that, as of December 31, 2012, the Company maintained effective internal control over financial reporting.

William C. Ulland

jOn GERlaCH

Chairman, President & CEO

Chief Financial Officer & V.P. Finance

report of independent regiStered pubLic accounting firM

TO ThE BOArD OF DIrECTOrS AND STOCKhOlDErS
IKONICS COrPOrATION

We have audited the accompanying balance sheets of IKONICS Corporation as of December 31, 2012 and 2011, and the related statements of income, stockholders’ equity,
and cash flows for the years then ended. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on
these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (united States). Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were
we engaged to perform an audit of its internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for de-
signing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control
over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the
financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presen-
tation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of IKONICS Corporation as of December 31, 2012 and
2011, and the results of its operations and its cash flows for the years then ended, in conformity with u.S. generally accepted accounting principles.

/s/ McGladrey llP
Minneapolis, Minnesota
March 5, 2013

IKONICS COrpOratION | 2012 AnnuAl RepoRtbaLance SheetS
DECEMBEr 31, 2012 AND 2011
aSSetS
CurrENT ASSETS:

2012

2011

Cash and cash equivalents (Note 7) ..............................................................................................................

967,943

Short-term investments ...............................................................................................................................

Trade receivables, less allowance of $43,000 in 2012 and $51,000 in 2011 (Notes 5, 7, and 9) .......................

Inventories (Notes 1 and 9) ..........................................................................................................................

Prepaid expenses and other assets ..............................................................................................................

Income tax receivable .................................................................................................................................

Deferred income taxes (Note 2) ....................................................................................................................

Total current assets ....................................................................................................................................

PrOPEr Ty, PlANT, AND EQuIPMENT , AT COST:

land and building .......................................................................................................................................

Machinery and equipment ...........................................................................................................................

Office equipment ........................................................................................................................................

Vehicles .....................................................................................................................................................

less accumulated depreciation ....................................................................................................................

1,442,939

2,060,312

2,678,864

124,983

142,000

7,417,041

6,063,965

3,219,598

700,062

237,488

10,221,113

4,759,235

5,461,878

INTANGIBlE ASSETS, less accumulated amortization of $482,107 in 2012 and $427,454 in 2011 (Note 3) .....................

305,357

LiabiLitieS and StockhoLderS’ equity
CurrENT lIABIlITIES:

13,184,276

2012

Accounts payable .......................................................................................................................................

593,922

Accrued compensation ................................................................................................................................

Other accrued liabilities ...............................................................................................................................

Income taxes payable ..................................................................................................................................

Total current liabilities .................................................................................................................................

DEFErrED INCOME TAXES (Note 2) ....................................................................................................................

Total liabilities ............................................................................................................................................

265,822

81,635

82,152

1,023,531

366,000

1,389,531

1,867,165

1,835,003

2,180,947

2,234,834

82,923

59,322

144,000

8,404,194

5,982,799

3,021,053

662,160

235,000

9,901,012

4,464,110

5,436,902

326,362

14,167,458

2011

549,532

244,173

45,210

838,915

338,000

1,176,915

STOCKhOlDErS’ EQuITy:

Preferred stock, par value $.10 per share; authorized 250,000 shares: issued none

Common stock, par value $.10 per share; authorized 4,750,000 shares: issued and outstanding 1,998,475
shares in 2012 and 1,984,587 shares in 2011 (Note 6)

Additional paid-in capital .............................................................................................................................

retained earnings .......................................................................................................................................

Total stockholders’ equity ............................................................................................................................

199,848

2,470,507

9,124,390

11,794,745

13,184,276

198,459

2,363,150

10,428,934

12,990,543

14,167,458

See notes to financial statements.

StateMentS of incoMe
yEArS ENDED DECEMBEr 31, 2012 AND 2011

NET SAlES ...............................................................................................................................................

17,312,407

16,780,262

COST OF GOODS SOlD ...............................................................................................................................

10,367,563

10,070,852

2012

2011

GrOSS PrOFIT ..........................................................................................................................................

SEllING, GENErAl AND ADMINISTrATIVE EXPENSES ......................................................................................

rESEArCh AND DEVElOPMENT EXPENSES ....................................................................................................

INCOME FrOM OPErATIONS ........................................................................................................................

INTErEST INCOME .....................................................................................................................................

INCOME BEFOrE INCOME TAXES ..................................................................................................................

FEDErAl AND STATE INCOME TAXES (NOTE 2) ...............................................................................................

NET INCOME .............................................................................................................................................

EArNINGS PEr COMMON ShArE:

6,944,844

5,282,187

629,776

5,911,963

1,032,881

12,050

1,044,931

351,000

693,931

Basic ......................................................................................................................................................................

Diluted ....................................................................................................................................................................

0.35

WEIGhTED AVErAGE COMMON ShArES:

6,709,410

5,171,147

512,259

5,683,406

1,026,004

17,253

1,043,257

345,000

698,257

0.35

Basic ......................................................................................................................................................................

Diluted ....................................................................................................................................................................

1,988,066

1,990,847

1,981,848

1,986,041

See notes to financial statements.

StateMentS of StockhoLderS’ equity
yEArS ENDED DECEMBEr 31, 2012 AND 2011

Balance at december 31, 2010

1,973,357

197,336

2,263,176

9,732,435

12,192,947

Common Shares

Stock amount

additional Paid-in
Capital

Retained Earnings

Total Stockholders’
Equity

Net Income

Exercise of stock options

Common Stock repurchased

Tax benefit resulting from stock option exercises

Stock based compensation and related tax benefit

Balance at december 31, 2011

Net income

Exercise of stock options

Cash dividend paid

Tax benefit resulting from stock option exercises

Stock based compensation and related tax benefit

Balance at december 31, 2012

See notes to financial statements.

11,500

(270)

1,984,587

13,888

1,150

(27)

198,459

1,389

72,060

(294)

1,518

26,690

698,257

(1,758)

698,257

73,210

(2,079)

1,518

26,690

2,363,150

87,639

10,428,934

693,931

12,990,543

693,931

89,028

(1,998,475)

1,900

17,818

1,900

17,818

1,998,475

199,848 $

2,470,507

9,124,390

11,794,745

IKONICS COrpOratION | 2012 AnnuAl RepoRt
StateMentS of caSh fLowS
yEArS ENDED DECEMBEr 31, 2012 AND 2011

CASh FlOW FrOM OPErATING ACTIVITIES:

2012

2011

Net Income ....................................................................................................................................................

693,931

698,257

ADJuSTMENTS TO rECONCIlE NET INCOME TO NET CASh PrOVIDED By OPErATING ACTIVITIES:

Depreciation ...................................................................................................................................................

489,206

Amortization ...................................................................................................................................................

Stock based compensation ..............................................................................................................................

Net gain on sale of vehicles and equipment exchange ........................................................................................

loss on intangible asset abandonment .............................................................................................................

Deferred income taxes ....................................................................................................................................

ChANGES IN WOrKING CAPITAl COMPONENTS:

Trade receivables ............................................................................................................................................

Inventories .....................................................................................................................................................

Prepaid expenses and other assets ..................................................................................................................

Income tax refund receivable ...........................................................................................................................

Accounts payable ...........................................................................................................................................

Accrued liabilities ...........................................................................................................................................

Income taxes payable ......................................................................................................................................

54,653

17,818

(7,163)

23,122

30,000

120,635

(444,030)

(42,060)

59,322

44,390

58,074

84,052

Net cash provided by operating activities ......................................................................................................

1,181,950

CASh FlOWS FrOM INVESTING ACTIVITIES:

Purchases of property and equipment ...............................................................................................................

Proceeds from sale of equipment and vehicles ..................................................................................................

Purchases of intangibles .................................................................................................................................

Purchases of short-term investments ...............................................................................................................

Proceeds from sale of short-term investments ...................................................................................................

Net cash used in investing activities .............................................................................................................

(566,519)

59,500

(56,770)

(1,857,990)

2,250,054

(171,725)

CASh FlOWS FrOM FINANCING ACTIVITIES:

repurchase of common stock ..........................................................................................................................

Cash dividend paid .........................................................................................................................................

(1,998,475)

Proceeds from exercise of stock options ...........................................................................................................

89,028

Net cash provided by (used in) financing activities .........................................................................................

(1,909,447)

415,821

50,471

26,690

(1,353)

805

180,000

(297,519)

(263,809)

(18,958)

(59,322)

107,702

(38,681)

(6,572)

793,532

(621,598)

10,200

(60,470)

(2,446,359)

2,829,346

(288,881)

(2,079)

73,210

71,131

NET INCrEASE (DECrEASE) IN CASh AND CASh EQuIVAlENTS ...................................................................................

(899,222)

575,782

CASh AND CASh EQuIVAlENTS AT BEGINNING OF yEAr .............................................................................................

1,867,165

1,291,383

CASh AND CASh EQuIVAlENTS AT END OF yEAr ......................................................................................................

967,943

SuPPlEMENTAl DISClOSurE OF CASh FlOW INFOrMATION

Cash paid for income taxes, net of refunds received of $61,650 and $4,090, respectively ....................................

177,626

1,867,165

230,894

SuPPlEMENTAl SChEDulE OF NONCASh OPErATING AND INVESTING ACTIVITIES

Equipment transferred from inventory to property, plant and equipment ...............................................................

227,039

See notes to financial statements

noteS to financiaL StateMentS
yEArS ENDED DECEMBEr 31, 2012 AND 2011

1. SUmmaRY OF SiGniFiCanT aCCOUnTinG POliCiES

inventories - Inventories are stated at the lower of cost or market using the last-in,
first-out (lIFO) method. If the first-in, first-out (FIFO) cost method had been used,
inventories would have been approximately $1,246,000 and $1,213,000 higher
than reported at December 31, 2012 and 2011, respectively. The major components
of inventories, net of the allowance for obsolescence, are as follows:

description of Business and Foreign Export Sales - IKONICS Corporation (the
Company) develops and manufactures high-quality photochemical imaging systems
for sale primarily to a wide range of printers and decorators of surfaces. Custom-
ers’ applications are primarily screen printing and abrasive etching. The Company’s
principal markets are throughout the united States. In addition, the Company sells
to Europe, latin America, Asia, and other parts of the world. The Company extends
credit to its customers, all on an unsecured basis, on terms that it establishes for
individual customers.

raw Materials

Work-in-progress

Finished goods

reduction to lIFO cost

Total Inventories

2012

2011

2,072,540

1,811,219

373,512

1,478,444

338,284

1,298,616

(1,245,632)

(1,213,285)

2,678,864

2,234,834

Foreign export sales approximated 31.9% of net sales in 2012 and 33.1% of net
sales in 2011. The Company’s trade receivables at December 31, 2012 and 2011
due from foreign customers were 34.4% and 35.9% of total trade receivables,
respectively. The foreign export receivables are composed primarily of open credit
arrangements with terms ranging from 30 to 90 days. No single customer or foreign
country represented greater than 10% of net sales in 2012 or in 2011.

The Company considers events or transactions that occur after the balance sheet
date but before the financial statements are issued to provide additional evidence
relative to certain estimates or to identify matters that require additional disclosure.
Subsequent events have been evaluated through March 5, 2013, the date the
financial statements were issued.

A summary of the Company’s significant accounting policies follows:

Cash Equivalents - The Company considers all highly liquid debt instruments
purchased with a maturity of three months or less to be cash equivalents. Cash
equivalents consist of money market funds in which the carrying value approximates
market value because of the short maturity of these instruments. The money market
fund utilized by IKONICS invests in united States dollar denominated securities that
present minimal credit risk and consist of investments in debt securities issued
or guaranteed by the united States government or by united States government
agencies or instrumentalities and repurchase agreements fully collateralized by the
united States Treasury and united States government securities.

Short-Term investments - Short-term investments consist of fully insured certifi-
cates of deposit with remaining maturities ranging from eight to twelve months as of
December 31, 2012 and 2011, respectively.

Trade Receivables - Trade receivables are carried at original invoice amount less
an estimate made for doubtful receivables based on a review of all outstanding
amounts on an on-going basis. Management determines the allowance for doubtful
accounts by regularly evaluating individual customer receivables and considering a
customer’s financial condition, credit history, and current economic conditions. Trade
receivables are written off when deemed uncollectible. recoveries of trade receiv-
ables previously written off are recorded when received. Accounts are considered
past due if payment is not received according to agreed-upon terms.

A small percentage of the trade receivables balance is denominated in a foreign
currency with no concentration in any given country. At the end of each report-
ing period, the Company analyzes the receivable balance for customers paying in
a foreign currency. These balances are adjusted to each quarter or year end spot
rate in accordance with FASB ASC 830, Foreign Currency Matters. Foreign currency
transactions and translation adjustments did not have a significant effect on the
Balance Sheet or the Statements of Income, Stockholders’ Equity and Cash Flows
for 2012 and 2011.

depreciation - Depreciation of property, plant and equipment is computed using
the straight-line method over the following estimated useful lives:

Buildings ............................................

Machinery and equipment ...................

Office equipment ................................

Vehicles .............................................

Years

15-40

5-10

3-10

intangible assets – Intangible assets consist of patents, licenses and covenants
not to compete arising from business combinations. Intangible assets are amor-
tized on a straight-line basis over their estimated useful lives or agreement terms.
Intangible assets with indefinite lives are assessed for impairment whenever events
or circumstances indicate the carrying value may not be fully recoverable by
comparing the carrying value of the intangibles to their future undiscounted cash
flows. To the extent the undiscounted cash flows are less than the carrying value,
analysis is performed based on several criteria, including, but not limited to, revenue
trends, discounted operating cash flows and other operating factors to determine
the impairment amount.

As of December 31, 2012 the remaining estimated weighted average useful lives of
intangible assets are as follows:

Patents ..............................................

licenses ............................................

Non-compete agreements ...................

Years

15.3

4.5

1.6

Fair Value of Financial instruments – The carrying amounts of financial instru-
ments, including cash and cash equivalents, short-term investments, accounts
receivable, accounts payable, and accrued liabilities approximate fair value due to
the short maturities of these instruments.

Revenue Recognition - The Company recognizes revenue on sales of products
when title passes which can occur at the time of shipment or when the goods ar-
rive at the customer location depending on the agreement with the customer. The
Company sells its products to both distributors and end-users. Sales to distributors
and end-users are recorded based upon the criteria governed by the sales, delivery,
and payment terms stated on the invoices from the Company to the purchaser. In
addition to transfer of title / risk of loss, all revenue is recorded in accordance with
the criteria outlined within SAB 104 and FASB ASC 605 revenue recognition:

(a) persuasive evidence of an arrangement (principally in the form of customer sales
orders and the Company’s sales invoices, as generally there is no other formal
agreement underlying the sale transactions)

(b) delivery and performance (evidenced by proof of delivery, e.g. the shipment of
film and substrates with bill of lading used for proof of delivery for FOB shipping
point terms, and the carrier booking confirmation report used for FOB destination

IKONICS COrpOratION | 2012 AnnuAl RepoRt

terms. Once the finished product is shipped and physically delivered under the
terms of the invoice and sales order, the Company has no additional performance or
service obligations to complete)

(c) a fixed and determinable sales price (the Company’s pricing is established and is
not based on variable terms, as evidenced in either the Company’s invoices or the
limited number of distribution agreements; the Company rarely grants extended pay-
ment terms and has no history of concessions)

Shares used in the calculation of diluted EPS are summarized below:

2012

2011

Weighted average common shares out-
standing ...............................................

1,988,066

1,981,848

Dilutive effect of stock options ................

2,781

4,193

Weighted average common and common
equivalent shares outstanding ................

1,990,847

1,986,041

(d) a reasonable likelihood of payment (the Company’s terms are standard, and the
Company does not have a substantial history of customer defaults or non-payment)

Self-Funded medical insurance - Beginning in January 2012, the Company
moved from a fully insured to a self-funded medical insurance plan. The Company
contracted with an administrative service company or a “third party administrator”
to supervise and administer the program and act as the Company’s fiduciary and
representative. The Company has reduced its risk under this self-funded plan by
purchasing both specific and aggregate stop-loss insurance coverage for individual
claims and total annual claims in excess of prescribed limits. The Company records
estimates for claim liabilities based on information provided by the third-party
administrators, historical claims experience, the life cycle of claims, expected costs
of claims incurred but not paid, and expected costs to settle unpaid claims. The
Company regularly monitors its estimated insurance-related liabilities. Actual claims
experience may differ from the Company’s estimates. Costs related to the admin-
istration of the plan and related claims are expensed as incurred. The total liability
for self-funded medical insurance was $54,000 as of December 31, 2012 and is
included within other accrued expenses in the balance sheet.

deferred Taxes - Deferred taxes are provided on a liability method whereby
deferred tax assets are recognized for deductible temporary differences and operat-
ing loss and tax credit carryforwards and deferred tax liabilities are recognized for
taxable temporary differences. Temporary differences are the differences between
the reported amounts of assets and liabilities and their tax bases. Deferred tax
assets are reduced by a valuation allowance when, in the opinion of management, it
is more likely than not that some portion or all of the deferred tax assets will not be
realized. Deferred tax assets and liabilities are adjusted for the effects of changes in
tax laws and rates on the date of enactment. The Company follows the accounting
standard on accounting for uncertainty in income taxes, which addresses the deter-
mination of whether tax benefits claimed or expected to be claimed on a tax return
should be recorded in the financial statements. under this guidance, the Company
may recognize the tax benefit from an uncertain tax position only if it is more likely
than not that the tax position will be sustained on examination by taxing authorities,
based on the technical merits of the position. The tax benefits recognized in the
financial statements from such a position are measured based on the largest benefit
that has a greater than 50 percent likelihood of being realized upon ultimate settle-
ment. The guidance on accounting for uncertainty in income taxes also addresses
derecognition, classification, interest and penalties on income taxes, and accounting
in interim periods.

Earnings per Common Share (EPS) - Basic EPS is calculated using net income
divided by the weighted average of common shares outstanding. Diluted EPS is
similar to Basic EPS except that the weighted average number of common shares
outstanding is increased to include the number of additional common shares, when
dilutive, that would have been outstanding if the potential dilutive common shares,
such as those shares subject to options, had been issued.

At December 31, 2011, options to purchase 5,000 shares of common stock with
a weighted average exercise price of $8.08 were outstanding, but were excluded
from the computation of common share equivalents because they were anti-dilutive.
There were no anti-dilutive options at December 31, 2012.

Employee Stock Plan - The Company accounts for employee stock options under
the provision of ASC 718 Compensation – Stock Compensation.

Use of Estimates - The preparation of the financial statements in conformity with
accounting principles generally accepted in the united States of America requires
management to make estimates and assumptions that affect the reported amounts
of assets and liabilities and disclosure of contingent assets and liabilities at the date
of the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates. Signifi-
cant estimates include the allowance for doubtful trade receivables, the reserve for
inventory obsolescence, self-funded health insurance, and the valuation allowance
for deferred tax assets.

2. inCOmE TaxES

Income tax expense for the years ended December 31, 2012 and 2011 consists of
the following:

2012

2011

Current:

Federal ..................................................

319,000

162,000

State .....................................................

deferred ...............................................

2,000

321,000

30,000

3,000

165,000

180,000

351,000

345,000

The expected provision for income taxes, computed by applying the u.S. federal
income tax rate of 35% in 2012 and 2011 to income before taxes, is reconciled to
income tax expense as follows:

2012

2011

Expected provision for federal income taxes .

365,700

365,100

State income taxes, net of federal benefit ....

Domestic manufacturers deduction .............

Non-deductible meals, entertainment, and life
insurance ..................................................

research and development credit ...............

Other ........................................................

(400)

(31,800)

20,800

(3,300)

2,200

(18,600)

20,700

(15,900)

(8,500)

351,000

345,000

Net deferred tax liabilities consist of the following as of December 31, 2012 and
2011:

The deferred tax amounts described above have been included in the accompanying
balance sheet as of December 31, 2012 and 2011 as follows:

2012

2011

deferred tax assets:

Accrued vacation .......................................

25,000

23,000

Inventories .................................................

101,000

107,000

Allowance for doubtful accounts .................

Allowance for sales returns .........................

5,000

11,000

8,000

10,000

Capital loss carryforward ............................

323,000

less valuation allowance ............................

(323,000)

142,000

148,000

deferred tax liabilities:

Property and equipment and other assets ....

(324,000)

(305,000)

Prepaid expenses .......................................

Intangible assets ........................................

(42,000)

(4,000)

(33,000)

Net deferred tax liabilities ...........................

(224,000)

$ (194,000)

Current Assets

Noncurrent liabilities

2012

2011

142,000

144,000

(366,000)

(338,000)

(244,000)

$ (194,000)

At December 31, 2012 and 2011, the Company established a valuation allowance
against its deferred tax asset related to the Company’s $919,000 loss on its invest-
ment in non-marketable equity securities since it is more likely that the deferred
tax asset will not be realized. The deferred tax asset and valuation allowance at
December 31, 2012 and December 31, 2011 was $323,000. As of December 31,
2012 the capital loss can be carried forward two years and must be offset by a
capital gain.

It has been the Company’s policy to recognize interest and penalties related to
uncertain tax positions in income tax expense. As of December 31, 2012 and 2011,
there was no liability for unrecognized tax benefits.

The Company is subject to federal and state taxation. The material jurisdictions that
are subject to examination by tax authorities primarily include Minnesota and the
united States, for tax years 2009, 2010, 2011 and 2012.

3. inTanGiBlE aSSETS

Intangible assets consist of patents, patent applications, licenses and covenants not to compete arising from business combinations. Capitalized patent application costs
are included with patents. Intangible assets are amortized on a straight-line basis over their estimated useful lives or terms of their agreement, whichever is shorter. The
Company wrote off costs related to patent applications of $23,000 in 2012 and $1,000 in 2011. No other impairment adjustments to intangible assets were made during
the years ended December 31, 2012 or 2011.

Intangible assets at December 31, 2012 and 2011 consist of the following:

december 31, 2012

december 31, 2011

Gross Carrying Amount

Accumulated Amortization

Gross Carrying Amount

Accumulated Amortization

amortized intangible assets:

Patents .....................................................................

$ 384,464

(141,447)

350,816

(130,166)

licenses ...................................................................

Non-compete agreements ..........................................

100,000

303,000

(83,334)

(257,326)

100,000

303,000

(75,628)

(221,660)

$ 787,464

(482,107)

753,816

(427,454)

aggregate amortization expense:

For the years ended December 31

2012

2011

Estimated amortization expense for the years ending december 31:

$54,653

$50,471

2013 ..................................................

$50,000

2014 ..................................................

2015 ..................................................

2016 ..................................................

2017 ..................................................

21,000

17,000

14,000

In connection with the license agreements, the Company has agreed to pay royalties ranging from 3% to 5% on the sales of products subject to the agreements. The
Company incurred $87,000 of expense under these agreements during 2012, and $94,000 during 2011 which have been included in selling, general and administrative
expenses in the Statements of Income.

IKONICS COrpOratION | 2012 AnnuAl RepoRt

4. RETiREmEnT Plan

The Company has established a salary deferral plan under Section 401(k) of the Internal revenue Code. Such deferrals accumulate on a tax-deferred basis until the
employee withdraws the funds. The Company contributes up to 5% of each eligible employee’s compensation. Total retirement expense for the years ended December 31,
2012 and 2011 was approximately $204,000 and $194,000, respectively.

5. SEGmEnT inFORma TiOn

The Company’s reportable segments are strategic business units that offer different products and have varied customer bases. There are four reportable segments: Do-
mestic, Export, IKONICS Imaging and Other. Domestic sells screen printing film, emulsions, and inkjet receptive film to distributors located in the united States and Canada.
IKONICS Imaging sells photo resistant film, art supplies, glass, metal medium and related abrasive etching equipment to end user customers located in the united States
and Canada. The Other segment includes products and customers for etched composites, ceramics, glass and silicon wafers along with sound deadening technology to the
aerospace industry, which the Company defines as Micromachining. In addition, the Other segment includes products and customers related to proprietary inkjet technology
used for mold texturing and referred to by the Company as Digital Texturing (DTX). Export sells primarily the same products as Domestic and the IKONICS Imaging products
not related to Micromachining or DTX. The accounting policies applied to determine the segment information are the same as those described in the summary of significant
accounting policies included in Note 1.

Management evaluates the performance of each segment based on the components of divisional income, and does not allocate assets and liabilities to segments except for
trade receivables which is allocated based on the previous segmentation. Financial information with respect to the reportable segments follows:

For the year ended december 31, 2012:

domestic

Export

iKOniCS
imaging

Other

Unallocated*

Total

Net sales ......................................................

7,118,912

5,523,177

3,708,987

961,331

Cost of goods sold .........................................

Gross profit ...................................................

Selling, general and administrative*..................

research and development* ............................

4,036,339

3,082,573

1,226,107

4,042,689

1,480,488

607,453

1,705,054

2,003,933

1,099,812

583,481

377,850

808,434

1,540,381

629,776

$ 17,312,407

10,367,563

6,944,844

5,282,187

629,776

Income (loss) from operations .........................

1,856,466

873,035

904,121

(430,584)

(2,170,157)

1,032,881

For the year ended december 31, 2011:

domestic

Export

iKOniCS
imaging

Other

Unallocated*

Total

Net sales ......................................................

6,680,562

5,556,455

3,582,268

960,977

Cost of goods sold .........................................

Gross profit ...................................................

Selling, general and administrative*..................

research and development* ............................

3,824,866

2,855,696

1,241,502

4,123,833

1,432,622

581,517

1,718,846

1,863,422

1,136,907

403,307

557,670

751,136

1,460,085

512,259

$ 16,780,262

10,070,852

6,709,410

5,171,147

512,259

Income (loss) from operations .........................

1,614,194

851,105

726,515

(193,466)

(1,972,344)

1,026,004

* The Company does not allocate all general and administrative expenses or any research and development expenses to its operating segments for internal reporting.

Trade receivables by segment as of December 31, 2012 and December 31, 2011 were as follows:

dec 31, 2012

dec 31, 2011

Domestic .......................................................

928,698

997,937

Export ............................................................

IKONICS Imaging ............................................

Other .............................................................

unallocated ....................................................

708,933

272,346

174,674

(24,339)

783,788

288,298

138,954

(28,030)

Total ..............................................................

$ 2,060,312

$ 2,180,947

6. STOCK OPTiOnS

The Company has a stock incentive plan for the issuance of up to 442,750 shares
of common stock. The plan provides for granting eligible participants stock options
or other stock awards, as described by the plan, at option prices ranging from 85%
to 110% of fair market value at date of grant. Options granted expire up to seven
years after the date of grant. Such options generally become exercisable over a
three year period. A total of 119,323 shares of common stock are reserved for ad-
ditional grants of options under the plan at December 31, 2012.

under the plan, the Company charged compensation cost of $17,818 and $26,690
against income in 2012 and 2011, respectively.

As of December 31, 2012, there was approximately $16,000 of unrecognized
compensation cost related to unvested share-based compensation awards granted
which is expected to be recognized over the next three years.

Proceeds from the exercise of stock options were $89,028 for 2012 and $73,210
for 2011.

The fair value of options granted during 2012 and 2011 were estimated using the
Black-Scholes option pricing model with the following assumptions:

Dividend yield ...........................................

2012

2011

Expected volatility .....................................

41.8%

40.5%-41.3%

Expected life of option ...............................

Five years

risk-free interest rate ...............................

Fair values of each option on grant date .....

0.8%

$2.73

Five years

1.0%-2.0%

$2.75-$2.83

There were 750 options and 9,000 options granted during 2012 and 2011,
respectively.

FASB ASC 718, Compensation – Stock Compensation specifies that initial accruals
be based on the estimated number of instruments for which the requisite service
is expected to be rendered. Therefore, the Company is required to incorporate a
preexisting forfeiture rate based on the historical forfeiture expense and prospective
actuarial analysis, estimated at 2%.

A summary of the status of the Company’s stock option plan as of December 31, 2012 and changes during the year then ended is presented below:

Options

Outstanding at January 1, 2012

Granted

Exercised

Expired and Forfeited

Outstanding at December 31, 2012

Vested or expected to vest at December 31, 2012

Exercisable at December 31, 2012

Weighted average Exercise Price

Contractual Term (years)

aggregate intrinsic Value

Weighted average Remaining

34,750

750

(13,888)

(250)

21,362

13,691

6.58

7.54

6.41

7.39

6.72

6.22

2.38

1.79

29,814

26,008

The weighted-average grant date fair value of options granted was $2.73 and $2.82 for the years ended December 31, 2012 and 2011, respectively. The total intrinsic
value of options exercised was $32,650 for the year ended December 31, 2012 and $20,687 for the year ended December 31, 2011.

The following table summarizes information about stock options outstanding at December 31, 2012:

Range of Exercise Price

Number Outstanding at

Weighted-Average remain-

Weighted-Average Exercise

Number Exercisable at

Weighted-Average Exercise

December 31, 2012

ing Contractual life (years)

Price

December 31, 2012

Price

Options Outstanding

Options Exercisable

6,362

2,500

12,500

21,362

1.31

0.58

3.28

2.38

5.00

6.71

7.60

6.72

6,362

2,500

4,829

13,691

5.00

6.71

7.56

6.22

$5.00-$5.99

$6.00-$6.99

$7.00-$8.99

IKONICS COrpOratION | 2012 AnnuAl RepoRt7. COnCEnTRa TiOn OF CREdiT RiSK

The Company maintains its cash balances primarily in two financial institutions. As of December 31, 2012, the balance at one of the institutions exceeded the Federal
Deposit Insurance Corporation coverage.

Trade receivables are financial instruments that also expose the Company to concentration of credit risk. The large number of customers comprising the Company’s cus-
tomer base and their dispersion across different geographic areas limits such exposure. In addition, the Company routinely assesses the financial strength of its customers
and maintains an allowance for doubtful accounts that management believes will adequately provide for credit losses.

8. linE OF CREdiT

The Company has a $1,250,000 bank line of credit that provides for working capital financing. This line of credit is subject to annual renewal on each October 30, is collat-
eralized by trade receivables and inventories, and bears interest at 2.5 percentage points over 30-day lIBOr. There were no outstanding borrowings under this line of credit
at December 31, 2012 and 2011. There are no financial covenants related to the line of credit.

9. nOn-mOnET aRY TRanSaCTiOn

During 2012, the Company entered into a like-kind exchange with a customer where the Company and the Company’s customer exchanged digital texturing printers. In
addition to the Company receiving a printer from the customer, the Company also received $35,000. A loss of $16,000 was recognized by the Company on the exchange.

COmmOn STOCK

addiTiOnal FinanCial inFORma TiOn

Stockholders of record automatically receive quarterly earnings information, and
street name holders may do so upon written request. For a copy of the Form 10-K,
as filed with the Securities and Exchange Commission, and other financial informa-
tion avail able at no charge to stockholders, please contact:

JON GErlACh
Chief Financial Officer

IKONICS Corporation
4832 Grand Avenue, Duluth, MN 55807
Phone: (218) 628-2217
email: jgerlach@ikonics.com

annUal mEETinG

The Company’s annual meeting will be held:

April 24, 2013 1:00 p.m.

Kitchi Gammi Club
831 E. Superior Street
Duluth, MN 55802

IKONICS Corporation common stock is traded on the Nasdaq Capital Market under
the symbol IKNX. For investment and stock information contact:

JON GErlACh
Chief Financial Officer

IKONICS Corporation
4832 Grand Avenue, Duluth, MN 55807
Phone: (218) 628-2217
email: jgerlach@ikonics.com

TRanSFER aGEnT

WEllS FArGO ShArEOWNEr SErVICES
PO Box 64854
St. Paul, MN 55164-0854

Shareholders with questions on stock holdings, transfer requirements and address
changes contact Wells Fargo Bank at: (800) 468-9716

aUdiTOR

MCGlADrEy llP
801 Nicollet Mall, Suite 110 West Tower
Minneapolis, MN 55802
(612) 573-8750

COUnSEl

hANFT FrIDE
1000 u.S. Bank Place
130 W. Superior Street
Duluth, MN 55802
(218) 722-4766

board of directorS

corporate officerS

ChArlES h. ANDrESEN

Attorney

WIllIAM C. ullAND

Chairman, President & CEO

Andresen & Butterworth P.A.

Duluth, MN

director Since 1979

ClA uDE PIGuET

Executive Vice President

lOCKWOOD CArlSON

President

Carlson Consulting Group

JON GErlACh

Vice President, Finance, CFO

Minneapolis, MN

director Since 2009

rONDI C. ErICKSON

Chief Executive Officer (retired 2006)

PArNEll ThIll

Vice President, marketing

Apprise Technologies, Inc.

Duluth, MN

director Since 2000

rOBErT D. BANKS

Vice President, international

ErNEST M. hArPEr, Jr.

Chief Tax Officer (retired 2010)

KArl ShAW

Chief Technology Officer

DAVID O. hArrIS

General Mills, Inc.

Minneapolis, MN

director Since 2012

President

David O. harris, Inc

Minneapolis, MN

director Since 1965

DArrEll B. lEE

Vice President, Chief Financial Officer,

Treasurer, Secretary

MOCON, Inc.

Minneapolis, MN

director Since 2012

h. lEIGh SEVErANCE

President

Severance Capital Management

Denver, CO

director Since 2000

GErAlD W. SIMONSON

President

Omnetics Connector Corporation

Minneapolis, MN

director Since 1978

WIllIAM C. ullAND

Chairman, President & CEO

IKONICS Corporation

Duluth, MN

director Since 1972

IKONICS COrpOratION | 2012 AnnuAl RepoRt$18,000,000

$16,000,000

$14,000,000

$12,000,000

$10,000,000

$8,000,000

$6,000,000

$4,000,000

$2,000,000

Net Sales 2008 – 2012

Net Income (Loss) 2008 – 2012

$1,400,000

$1,200,000

$1,000,000

$800,000

$600,000

$400,000

$200,000

- $200,000

- $400,000

2008

2009

2010

2011

2012

2008

2009

2010

2011

2012

IKONICS Five-Year History

2008

2009

2010

2011

2012

Net Sales

Pretax Income (Loss)

Net Income (Loss)

$15,854,484

$15,121,617

$16,517,338

$16,780,262

$17,312,407

$1,085,134

$(11,360)

$1,553,920

$1,043,257

$1,044,931

$814,134

$(307,360)

$1,113,920

$698,257

$693,931

Net Cash Provided by Operations

$1,125,668

$1,374,114

$1,601,369

$793,532

$1,181,950

Return on Sales

Return on Assets

Return on Avg. Stockholders' Equity

Debt to Equity

Diluted EPS

Stock price: High

Low

5.1%

6.5%

7.2%

9.2%

$0.40

$10.50

$5.25

$5.74

(2.0%)

(2.6%)

(2.7%)

8.8%

$(0.16)

$8.29

$4.00

$6.30

6.7%

8.5%

9.6%

7.8%

$0.56

$8.00

$6.30

$7.25

4.2%

4.9%

5.5%

9.1%

$0.35

$8.94

$6.90

$7.57

4.0%

5.3%

5.6%

11.8%

$0.35

$9.45

$7.03

$8.05

Weighted Average Common Shares Outstanding - Diluted

2,053,733

1,973,739

1,973,447

1,986,041

1,990,847

Total Assets

Total Liabilities

Total Stockholders' Equity

Capital Spending

$12,486,429

$11,997,272

$13,141,931

$14,167,458

$13,184,276

$1,052,789

$971,186

$948,984

$1,176,915

$1,389,531

$11,433,640

$11,026,086

$12,192,947

$12,990,543

$11,794,745

$4,472,681

$90,313

$189,150

$621,598

$566,519

4832 Grand Avenue Duluth, MN 55807 ph: (218) 628-2217 toll-free: (800) 328-4261 e: info@ikonics.com web: www.ikonics.com